
Que Tan Le
Examiner (ID: 7457, Phone: (571)272-2438 , Office: P/2878 )
| Most Active Art Unit | 2878 |
| Art Unit(s) | 2878, 2509, 2505 |
| Total Applications | 3981 |
| Issued Applications | 3596 |
| Pending Applications | 114 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17082322
[patent_doc_number] => 20210277328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MUSK COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/209056
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209056 | Musk compositions and methods of use thereof | Mar 21, 2021 | Issued |
Array
(
[id] => 20262988
[patent_doc_number] => 12433956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Method of administering a nanoparticle
[patent_app_type] => utility
[patent_app_number] => 17/907029
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 9371
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907029 | Method of administering a nanoparticle | Mar 18, 2021 | Issued |
Array
(
[id] => 17080470
[patent_doc_number] => 20210275476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => BACTERICIDAL AND VIRUCIDAL PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/199822
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199822 | Bactericidal and virucidal pharmaceutical composition | Mar 11, 2021 | Issued |
Array
(
[id] => 16898757
[patent_doc_number] => 20210177673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => METHOD OF MANAGING DIFFERENT STAGES IN A WOMEN'S LIFE
[patent_app_type] => utility
[patent_app_number] => 17/189166
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189166 | METHOD OF MANAGING DIFFERENT STAGES IN A WOMEN'S LIFE | Feb 28, 2021 | Abandoned |
Array
(
[id] => 19503782
[patent_doc_number] => 12115180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => PH responsive drug conjugated nanocarriers
[patent_app_type] => utility
[patent_app_number] => 17/188891
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 39
[patent_no_of_words] => 16391
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188891 | PH responsive drug conjugated nanocarriers | Feb 28, 2021 | Issued |
Array
(
[id] => 19896914
[patent_doc_number] => 12274810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Methods, kits and compositions for novel agarose-based dermal filler with enhanced rheological properties providing safety features
[patent_app_type] => utility
[patent_app_number] => 17/185371
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5111
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185371 | Methods, kits and compositions for novel agarose-based dermal filler with enhanced rheological properties providing safety features | Feb 24, 2021 | Issued |
Array
(
[id] => 17049820
[patent_doc_number] => 20210259254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => ANTIFUNGAL COMPOSITIONS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/183391
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183391 | ANTIFUNGAL COMPOSITIONS AND METHODS OF USING SAME | Feb 23, 2021 | Abandoned |
Array
(
[id] => 17050542
[patent_doc_number] => 20210259976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/180338
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180338 | POLYMER-ENCAPSULATED DRUG PARTICLES | Feb 18, 2021 | Pending |
Array
(
[id] => 18299805
[patent_doc_number] => 20230109491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => EDB-FN AS BIOMARKER OF CANCER AND/OR BRAIN DISEASE AND NANODRUG DELIVERY SYSTEM TARGETING SAME
[patent_app_type] => utility
[patent_app_number] => 17/800202
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800202 | EDB-FN AS BIOMARKER OF CANCER AND/OR BRAIN DISEASE AND NANODRUG DELIVERY SYSTEM TARGETING SAME | Feb 16, 2021 | Pending |
Array
(
[id] => 17005380
[patent_doc_number] => 20210236541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/176782
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176782 | IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL | Feb 15, 2021 | Abandoned |
Array
(
[id] => 18252294
[patent_doc_number] => 20230079333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SUPPLEMENTED ANIMAL FEEDS FOR MAMMALS
[patent_app_type] => utility
[patent_app_number] => 17/799805
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799805 | SUPPLEMENTED ANIMAL FEEDS FOR MAMMALS | Feb 14, 2021 | Pending |
Array
(
[id] => 17790450
[patent_doc_number] => 20220249541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => POLYSACCHARIDE CARBON NANOGELS AND ANTICOAGULANTS AND ANTIOXIDANTS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/169637
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169637 | Polysaccharide carbon nanogels and anticoagulants and antioxidants comprising the same | Feb 7, 2021 | Issued |
Array
(
[id] => 17255800
[patent_doc_number] => 20210368785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => DISPERSION AND METHOD AND COMPOSITION FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/147300
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147300 | Dispersion and method and composition for preparing the same | Jan 11, 2021 | Issued |
Array
(
[id] => 16806245
[patent_doc_number] => 20210128798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => HEMOSTATIC DEVICES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/144758
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144758 | Hemostatic devices and methods of use | Jan 7, 2021 | Issued |
Array
(
[id] => 18091314
[patent_doc_number] => 20220409655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PLATELET AGGREGATING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/756752
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756752 | PLATELET AGGREGATING AGENT | Jan 6, 2021 | Abandoned |
Array
(
[id] => 18264409
[patent_doc_number] => 20230085651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 17/787787
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787787 | ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF PSORIASIS | Dec 21, 2020 | Pending |
Array
(
[id] => 16748741
[patent_doc_number] => 20210100750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Compositions for Treatment of Attention Deficit Hyperactivity Disorder
[patent_app_type] => utility
[patent_app_number] => 17/124102
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124102 | Compositions for treatment of attention deficit hyperactivity disorder | Dec 15, 2020 | Issued |
Array
(
[id] => 19256331
[patent_doc_number] => 12016355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Stevia composition
[patent_app_type] => utility
[patent_app_number] => 17/118702
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 6863
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118702 | Stevia composition | Dec 10, 2020 | Issued |
Array
(
[id] => 16710269
[patent_doc_number] => 20210077416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => Compositions for Treatment of Attention Deficit Hyperactivity Disorder
[patent_app_type] => utility
[patent_app_number] => 17/108710
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108710 | Compositions for treatment of attention deficit hyperactivity disorder | Nov 30, 2020 | Issued |
Array
(
[id] => 18075858
[patent_doc_number] => 20220401470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => CARBAZATE-ACTIVATED POLYVINYL ALCOHOL (PVAC) AS A POLYMER-BASED ANTITUMORAL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/776643
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776643 | Carbazate-activated polyvinyl alcohol (PVAC) as a polymer-based antitumoral agent | Nov 17, 2020 | Issued |